PMID- 2536931 OWN - NLM STAT- MEDLINE DCOM- 19890316 LR - 20190501 IS - 0027-8424 (Print) IS - 1091-6490 (Electronic) IS - 0027-8424 (Linking) VI - 86 IP - 3 DP - 1989 Feb TI - Platelet-derived growth factor synthesis in mesangial cells: induction by multiple peptide mitogens. PG - 1056-60 AB - Platelet-derived growth factor (PDGF) has been implicated in several nonmalignant pathophysiological processes, including proliferative diseases of the kidney. Glomerular mesangial cells secrete a PDGF-like factor and express the PDGF A-chain and c-sis (or B-chain) mRNAs. We report here that both mRNAs are induced by serum and this effect can be mimicked by recombinant PDGF, which also markedly stimulates DNA synthesis. Other growth factors, such as epidermal growth factor (EGF), transforming growth factor type alpha, basic fibroblast growth factor (bFGF), and tumor necrosis factor type alpha (TNF-alpha) also are mitogenic for human mesangial cells and induce expression of the PDGF mRNAs. EGF, TNF-alpha, and bFGF also stimulate these cells to secrete a PDGF-like factor. Furthermore, anti-PDGF antibody partially abrogates the mitogenic effect of EGF, suggesting that mitogen-stimulated PDGF synthesis in mesangial cells is at least partly responsible for cell growth induced by other growth factors. In contrast to these results, transforming growth factor type beta (TGF-beta), while inducing both mRNAs, is not mitogenic, indicating that its effect on message levels can be dissociated from DNA synthesis. These data suggest that several peptide growth factors regulate the growth of mesangial cells and that PDGF may be an effector molecule that plays a role in the mitogenic response to many of these growth stimuli. FAU - Silver, B J AU - Silver BJ AD - Division of Hematology/Oncology, Cleveland Veterans Administration, Case Western Reserve University, OH 44106. FAU - Jaffer, F E AU - Jaffer FE FAU - Abboud, H E AU - Abboud HE LA - eng GR - AM07470/AM/NIADDK NIH HHS/United States GR - DK33665/DK/NIDDK NIH HHS/United States GR - P30CA43703/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (Macromolecular Substances) RN - 0 (Mitogens) RN - 0 (Platelet-Derived Growth Factor) RN - 0 (RNA, Messenger) RN - 0 (Receptors, Cell Surface) RN - EC 2.7.10.1 (Receptors, Platelet-Derived Growth Factor) SB - IM MH - Blotting, Northern MH - Cells, Cultured MH - DNA Replication MH - Gene Expression Regulation/drug effects MH - Genes MH - Glomerular Mesangium/drug effects/*metabolism MH - Humans MH - Macromolecular Substances MH - Mitogens/*pharmacology MH - Platelet-Derived Growth Factor/biosynthesis/*genetics MH - RNA, Messenger/drug effects/genetics MH - Receptors, Cell Surface/metabolism MH - Receptors, Platelet-Derived Growth Factor PMC - PMC286620 EDAT- 1989/02/01 00:00 MHDA- 1989/02/01 00:01 PMCR- 1989/08/01 CRDT- 1989/02/01 00:00 PHST- 1989/02/01 00:00 [pubmed] PHST- 1989/02/01 00:01 [medline] PHST- 1989/02/01 00:00 [entrez] PHST- 1989/08/01 00:00 [pmc-release] AID - 10.1073/pnas.86.3.1056 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 1989 Feb;86(3):1056-60. doi: 10.1073/pnas.86.3.1056.